Trial intelligence / Profile preview

GNB+IPACK vs ACB for Pain Control in TKA

NCT06423339Completed

Sponsor
Ain Shams University
Start
May 2024
Primary completion
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Total Postoperative Morphine Consumption at 48 hours. Started May 2024; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06423339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06423339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call